Neurological conditions such as Parkinson’s disease and cerebral stroke often severely affect walking and balance abilities. Patients find these motor symptoms extremely disabling with a consequential loss of self-confidence, independence and quality of life. Current treatments fail to address these situations. The Swiss company GONDOLA Medical Technologies brings a unique, patient-friendly, solution.
GONDOLA, has developed a medical device (GONDOLA®) to treat patients with walking impairments due to neurological disorders, such as Parkinson’s disease and stroke. GONDOLA device is a ground breaking innovation that delivers AMPS, Automated Mechanical Peripheral Stimulation, a short-duration, non-invasive treatment, consisting of specific stimulations to very specific target points on each foot of the patient. The treatment can be self-administered using the GONDOLA device, thus providing patients an at-home neuro-rehabilitation option for the first time ever. A professional version of the device to be used in hospitals and rehabilitation centers is also available.
Gondola AMPS is a game-changing innovation that provides the following benefits for patients:
- address walking and balance disabilities of Parkinson's patients and stroke survivors,
- offer a non-intrusive solution to patients in the advanced and most debilitating stages of the conditions,
- deliver the treatment in a least constraining form with an aim at favoring adherence,
- provide a cost-effective solution, fit for different purposes: home care and medical environments,
- doing all of this while reducing psychological distress.
In an ageing Europe, GONDOLA AMPS can make a significant contribution towards ageing in good health thereby reducing the cost of long-term care to societies.
Thanks to a strong clinical research team, GONDOLA has gained a clear understanding of the mechanisms of action of GONDOLA-EK01. Benefits of the therapy delivered by GONDOLA device are achieved through the enhancement of the automaticity of the walking neural networks. These processes are known to play a role in the fundamental principles of rehabilitation of patients with acute brain lesion (e.g. stroke), neurodegenerative diseases affecting mobility (e.g. Parkinson’s disease), and chronic neurological conditions (e.g. cerebral palsy). Based on this evidence, and a documented unmet need in walking rehabilitation for neurological disorders, a broad patient population can benefit from the use of AMPS treatment delivered via the GONDOLA medical device.
Large use of GONDOLA AMPS can alleviate care needs of patients and their families, and reduce cost of care for national health systems. Furthermore, the recent COVID pandemic has emphasized and accelerated the need for rehabilitation innovations, especially those that can be performed at home in conjunction with telemedicine.
